로딩 중…
StockDiggingStockDigging

JVM

054950· KOSDAQ
₩21,500-2.05%
2026-06-19

Price Chart

JVM-13.83%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap259.93B KRW
Revenue175.79B KRW
Net Income28.17B KRW
Total Assets325.91B KRW
Net Assets233.91B KRW
Employees317
Value
P/E9.23x
P/B1.11x
P/S1.48x
EV/EBITDA8.33x
FCF Yield9.11%
Profitability
ROE12.04%
ROA8.64%
Op. Margin19.17%
Revenue Growth6.22%
Earnings Growth-2.36%
Financial Health
Debt Ratio139.33%
Total Debt31.46B KRW
FCF23.68B KRW
Cash10.68B KRW
Current Ratio2.53x
Net Debt/EBITDA0.62x
Dividend
Div. Yield2.96%
Div. Growth30.00%
Performance
1Y Return-13.83%
1M Return-5.70%
From 52W High-37.68%
1Y MDD-36.69%
Trading
Volume21,269 shares
Foreign Own.17.67%
Per Share
EPS2,330 KRW
BPS20,275 KRW

Company Info

CEO 이동환
Employees 317
Founded 1977
HQ 대구광역시 달서구, KR

JVM, established in 1977 for equipment development, production, and sales, was listed on KOSDAQ in 2006 and became a subsidiary of Hanmi Pharmaceutical Group in 2016. The company researches, develops, produces, and sells hospital and pharmacy automation systems and related software using its proprietary technology, boasting a diverse product lineup. JVM focuses on R&D and production of next-generation products, supplying equipment to 60 countries through global partners to expand its market presence. It is headquartered in Dalseo-gu, Daegu Metropolitan City.